Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Purpose-built for physicians GLP-1, SGLT2 combination therapy provides largest weight loss for women with PCOS Combination therapy with a GLP-1 receptor agonist and an SGLT2 inhibitor may provide better weight-loss benefits than a single agent for women with polycystic ovary syndrome and obesity, according to study data
TRIUMPH-4 data suggests retatrutide delivers on both fronts, though a dedicated cardiovascular outcomes trial running through 2027-2028 will provide definitive proof
How this study might affect research, practice or policy
Lose weight, restore energy, and feel like yourself again
US$ 27.20
US$ 29.91
US$ 25.03
US$ 25.03
US$ 21.50
US$ 27.69
US$ 22.75
